Mannheim, Germany

Markus Mägerlein

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Markus Mägerlein

Introduction

Markus Mägerlein is a distinguished inventor based in Mannheim, Germany, recognized for his innovative contributions to the field of pharmaceuticals. With a total of three patents to his name, Mägerlein has focused his research on enhancing drug delivery systems through advanced dosage forms that incorporate solid dispersions of active ingredients.

Latest Patents

Mägerlein's latest patents highlight his expertise in pharmaceutical formulation. One notable patent describes a method for producing dosage forms comprising a solid dispersion of a microcrystalline active substance. This method involves melting a thermoplastic polymer and dissolving the active substance within it, followed by initiating crystallization and cooling the mass. This innovative technique can significantly improve the stability and efficacy of pharmaceutical products.

Another patent focuses on a pharmaceutical dosage form that includes a solid dispersion product of at least one active ingredient in a polymeric binder composition. The composition features a vinylpyrrolidone homopolymer and a copolymer, with the dosage form prepared via a melt extrusion process. This formulation not only enhances drug dissolution power but also reduces viscosity without compromising mechanical properties and storage stability.

Career Highlights

Throughout his career, Markus Mägerlein has worked with prominent companies, including AbbVie Deutschland GmbH & Co. KG, where he honed his skills in pharmaceutical development. His expertise in innovative drug formulations has made significant contributions to the industry and has paved the way for further advancements in medication delivery systems.

Collaborations

Mägerlein has collaborated with esteemed professionals such as Bernd Liepold and Jörg Breitenbach, indicating a strong network within the research community. These collaborations have enabled him to refine his inventions and share knowledge with peers, further enhancing the quality of his work.

Conclusion

Markus Mägerlein stands out as a noteworthy inventor in the pharmaceutical sector, with a specific focus on improving drug delivery systems through innovative dosage forms. His patents reflect a deep understanding of polymer chemistry and its applications in pharmacy, promising to make a lasting impact on the field. As he continues his research, the pharmaceutical community eagerly anticipates the potential outcomes of his work, which may revolutionize how medications are administered and absorbed in the body.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…